This time of year people eat more in terms of quantity and variety. Whatever people celebrate, there are dishes that might not be eaten any other time.
For the person being treated for lymphoma, this may be a frustration. Traditional chemotherapy or radiotherapy may leave a person with nausea. Or the taste of certain foods may change. Or both (like me).
You may have to experiment to see what foods are appealing. Maybe some dishes can be frozen until the worst of the cycle of chemo is over. Make sure you talk to your medical team about nutrician - you'll want to eat as healthy as possible.
I promised myself that after treatment I'd have a different attitude towards food. Ten years out, I still have it - I enjoy food, sometimes eating a dessert as a meal or an appetizer & dessert together. For the hell we go through to reach remission, we deserve a bit of a break.
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...